Study Overview
Atopic dermatitis, commonly known as eczema, is a chronic, inflammatory skin condition characterized by intense itching, dry skin, and red or discolored rashes. It can occur due to a combination of genetic factors, immune system overactivity, and a compromised skin barrier. The condition is driven by a dysfunctional skin barrier that fails to retain moisture and protect against allergens, irritants, and bacteria. This leads to inflammation and a persistent itch-scratch cycle that can cause skin thickening, oozing, and increased susceptibility to infections.
In this study, we use substances that cause inflammation to create an atopic dermatitis-like condition in normal human skin cells. We subsequently administered a test substance to understand if it is able to improve this phenotype.
*All our studies are mainly performed and handled by our team of PhD scientists.
